Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 1 Relevant journals, 157 Conference proceedings are presently dedicated exclusively to rheumatoid arthritis and about 108 Open access articles , 45 National symposiums are being published on rheumatoid arthritis.
Rheumatoid arthritis is a chronic disease in which inflammatory changes occur throughout the connective tissues of the body. Rheumatoid arthritis usually first attacks joints of the hands and feet symmetrically before progressing to the wrists, knees, or shoulders; the onset of the disorder is gradual. Pain and stiffness in one or more small joints are usually followed by swelling and heat and are accompanied by muscle pain that may become worse, persist for weeks or months, or subside. Rheumatoid arthritis is about three times as common in women as in men and afflicts about 1 percent of the adult population in the developed nations; it is much less common than osteoarthritis, which is associated with aging.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Rheumatoid Arthritis Conference provides the scope for opportunities to learn progressed by international scientists and academicians. Rheumatoid Arthritis Conference offers excessive quality content to suit the diverse professional development of these medicines to treat people all over the globe. It is a perfect platform to discuss the current discoveries and developments in the field of Rheumatology. Diagnosis of RA involves the Physical exam and radiographs as it is an auto immune disease it affects the autoimmunity. Among the developed countries USA UK arthritis is a common problem. Women’s are more likely to get RA due to hormones and hereditary and life style. The causes for RA are not exactly known but genetic factors are expected to play a major role. Vitamin D deficiency is also found to be common with those with RA than without RA.
Rheumatoid Arthritis is an autoimmune disease that causes chronic inflammation of the joints. Autoimmune diseases are illnesses that occur when the body's tissues are mistakenly attacked by their own immune system. The immune system contains a complex organization of cells and antibodies designed normally to "seek and destroy" invaders of the body, particularly infections. Patients with autoimmune diseases have antibodies and immune cells in their blood that target their own body tissues, where they can be associated with inflammation. Rheumatoid Arthritis conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of:
1. Rheumatoid Arthritis
3. Septic arthritis
It also provides the platform for researchers, scholars and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Rheumatology.
Rheumatoid arthritis an auto immune disease that results in chronic, systemic inflammatory disorder that may affect many tissues and organs but principally attacks the synovial joints. It may leads to disabling and loss of functioning if not adequately treated. Primarily it involves an inflammatory response of the capsule around the synovium and leads to swelling of synovial cells and development of Pannus (unwanted tissue layer) in the joint. This process finally leads to the destruction of articular cartilage and Ankylosis (stiffness of the joint due to the abnormal adhesion). It also produces inflammation in the lungs and leads to Pericardium (membrane around the heart).
Rheumatoid Arthritis is an autoimmune disease that mainly attacks the synovial tissues around the joints. Out of every 100,000 people, 41 are diagnosed with Rheumatoid arthritis every year. The life time risk of developing rheumatoid arthritis is 4% in women and 3% in men. Global rheumatoid arthritis market is driven by increase in incidences of RA patients, global ageing population and increasing healthcare expenditure by government of various nations. Factors which are affecting pharmaceutical companies are pricing pressure, patent expiries of RA drugs, high costs of treatments involved and escalating R&D costs. The market is characterized by use of auto-injectors by patients for RA treatment, increase in RA cases in women and FDA approvals for RA drugs. The market for Rheumatoid arthritis therapeutics is expected to increase from $56.6 billion in 2013 to $80.7 billion in 2020, at a Compound Annual Growth Rate (CAGR) of 5.2%. The global Rheumatoid Arthritis (RA) treatment market is expected to increase in value, from $14.3 billion in 2013 to just over $19 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 4.1% according to GBI research. According to 2013 more than 1.3 million of US population has RA which stands in third place following Oestoarthritis and Gout. Rheumatoid Arthritis is mostly a female dominant disease as most commonly seen in women’s. There are 2.5 times as many as women as there are men with RA. RA can occur in any part of life but mostly occurs in fourth and fifth decades of life.
4. Internal Medicine Conference
November 03-05, 2016 Baltimore, Maryland, USA
5. Healthcare Conference
October 05-07, 2015 New Delhi, India
7. Musculoskeletal Regeneration Conference
May 05-06, 2016 Chicago, USA
8. Biomaterials Conference
March 14-16, 2016 London, UK
10. Novel Physiotherapies Conference
October 20-22, 2016 Kuala Lumpur, Malaysia
16. ICOR 2016: 18th International Conference on Orthopedics and Rheumatology
March 1 - 2, 2016, Miami, USA
17. The Shoulder – Internationale Konferenz Shoulder Revision Arthroplasty 2016
January 15-16, 2016, Hambourg, Germany
18. Oswestry Intensive Course in Basic Science in Orthopaedics 2016
January 10-15, 2016, Oswestry, United Kingdom
19. Freiburger Knorpeltage 2016 – Fribourg Cartilage 2016
February 19-20, 2016, Freiburg, Germany
20. 36th Overseas Orthopaedic Meeting and 3° Indian Ocean Spine Meeting
March 26- April 02, 2016, Saint Gilles Ile de la Réunion, France.
21. Osteoarthritis Research Society International (OARSI) 2016 World Congress
March 31 - April 3, 2016 - Amsterdam, Netherlands
Relevant Society and Associations
1. Arthritis Foundation
2. National Rheumatoid Arthritis Society
3. International League of Associations for Rheumatoid
4. European Rheumatoid Arthritis Surgical
5. Australian Rheumatology Association
6. Arthritis Ireland
7. New Zealand Rheumatology Association
8. Arthritis and Musculoskeletal Alliance
9. NRAS National Rheumatoid Arthritis Society
10. The International Autoimmune Arthritis Movement (IAAM)
11. The Arthritis Society
12. American Arthritis Society
13. Brittle Bone Society
14. Bone Research Society
15. Australian Orthopaedic Association
16. American Association of Orthopaedic Surgeons
17. Australian Orthopedic Foot and Ankle Society
18. British Foot and Ankle Society
19. Asia Pacific Orthopaedic Association
20. Swedish Orthopaedic Association
1. Novartis International AG,
2. Jassen biotech Inc
3. Crescendo Bioscience
4. Inova Diagnostics
9. Johnson & Johnson
11. Eli Lilly
12. Novo Nordisk A/s
13. Teva Pharmaceutical Industries Ltd.
14. TransPharma Medical Ltd.
15. Zelos Therapeutics Inc
16. Velcura Therapeutics, Inc
17. Tornier, Inc. / LifeCell Corporation
18. Osteologix, Inc.
19. Unigene Laboratories, Inc.
20. Tethys Bioscience, Inc.
21. Ligand Pharmaceuticals Incorporated
This page will be updated regularly.
This page was last updated on January 27, 2021